Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 21 | 2004 | 331 | 1.170 |
Why?
|
| Erythroid Precursor Cells | 4 | 1994 | 19 | 0.380 |
Why?
|
| Bone Marrow | 4 | 2004 | 317 | 0.330 |
Why?
|
| Fetal Hemoglobin | 3 | 1994 | 27 | 0.220 |
Why?
|
| Primary Myelofibrosis | 1 | 2004 | 51 | 0.200 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1993 | 12 | 0.190 |
Why?
|
| Splenic Diseases | 2 | 1992 | 28 | 0.180 |
Why?
|
| Developmental Disabilities | 2 | 1993 | 780 | 0.130 |
Why?
|
| Hemin | 2 | 1993 | 14 | 0.130 |
Why?
|
| Interleukin-3 | 2 | 1993 | 16 | 0.110 |
Why?
|
| Comprehensive Health Care | 1 | 1995 | 13 | 0.110 |
Why?
|
| Interview, Psychological | 1 | 1994 | 102 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 1994 | 88 | 0.100 |
Why?
|
| Hemoglobinopathies | 1 | 1992 | 14 | 0.090 |
Why?
|
| Spherocytosis, Hereditary | 1 | 1992 | 6 | 0.090 |
Why?
|
| DNA | 3 | 1994 | 1400 | 0.090 |
Why?
|
| Friend murine leukemia virus | 1 | 1992 | 1 | 0.090 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1992 | 3 | 0.090 |
Why?
|
| Hemoglobinometry | 1 | 1992 | 3 | 0.090 |
Why?
|
| Growth Disorders | 1 | 1992 | 183 | 0.090 |
Why?
|
| Health Care Costs | 1 | 1995 | 401 | 0.080 |
Why?
|
| Priapism | 1 | 1990 | 11 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1994 | 833 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 1994 | 460 | 0.080 |
Why?
|
| Educational Measurement | 1 | 1993 | 316 | 0.080 |
Why?
|
| Penis | 1 | 1990 | 83 | 0.080 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 31 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 1992 | 331 | 0.070 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1990 | 81 | 0.070 |
Why?
|
| Mass Screening | 1 | 1994 | 808 | 0.070 |
Why?
|
| Prostanoic Acids | 1 | 1987 | 1 | 0.060 |
Why?
|
| Lung Diseases | 2 | 1995 | 396 | 0.060 |
Why?
|
| Infarction | 1 | 1987 | 20 | 0.060 |
Why?
|
| Rhabdomyosarcoma | 1 | 1990 | 229 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2004 | 3753 | 0.060 |
Why?
|
| Lipids | 1 | 1990 | 558 | 0.060 |
Why?
|
| Child | 13 | 2004 | 26097 | 0.060 |
Why?
|
| Sepsis | 1 | 1990 | 494 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 1990 | 563 | 0.050 |
Why?
|
| Fatty Acids | 1 | 1987 | 373 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2004 | 92 | 0.050 |
Why?
|
| Humans | 26 | 2004 | 130342 | 0.050 |
Why?
|
| Adolescent | 9 | 2004 | 20718 | 0.050 |
Why?
|
| Erythrocytes | 3 | 1992 | 188 | 0.050 |
Why?
|
| Tritium | 2 | 1992 | 108 | 0.040 |
Why?
|
| Child, Preschool | 6 | 2004 | 14949 | 0.040 |
Why?
|
| Erythropoietin | 2 | 1993 | 103 | 0.040 |
Why?
|
| Male | 13 | 2004 | 64409 | 0.040 |
Why?
|
| Vasculitis | 2 | 1993 | 46 | 0.040 |
Why?
|
| Adult | 8 | 2004 | 31121 | 0.040 |
Why?
|
| Autopsy | 3 | 2003 | 112 | 0.040 |
Why?
|
| Blood Cells | 1 | 1997 | 53 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1997 | 143 | 0.030 |
Why?
|
| Female | 10 | 2004 | 70331 | 0.030 |
Why?
|
| Erythrocyte Membrane | 2 | 1997 | 19 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 1994 | 3362 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 1992 | 2895 | 0.030 |
Why?
|
| Pain | 3 | 1988 | 428 | 0.030 |
Why?
|
| Infant | 3 | 2004 | 13239 | 0.030 |
Why?
|
| Meperidine | 1 | 1995 | 5 | 0.030 |
Why?
|
| Episode of Care | 1 | 1995 | 3 | 0.030 |
Why?
|
| Alabama | 1 | 1995 | 44 | 0.030 |
Why?
|
| S Phase | 1 | 1994 | 76 | 0.030 |
Why?
|
| Hemoglobin A | 2 | 1992 | 11 | 0.030 |
Why?
|
| Sampling Studies | 1 | 1994 | 76 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1993 | 14 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 56 | 0.030 |
Why?
|
| Hemoglobins | 2 | 1993 | 286 | 0.030 |
Why?
|
| Psychomotor Disorders | 1 | 1993 | 30 | 0.020 |
Why?
|
| Self Concept | 1 | 1994 | 156 | 0.020 |
Why?
|
| Fatigue | 1 | 1994 | 192 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 1995 | 233 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1993 | 91 | 0.020 |
Why?
|
| Hemoglobin SC Disease | 2 | 1990 | 7 | 0.020 |
Why?
|
| Thalassemia | 2 | 1990 | 9 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1995 | 226 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1997 | 999 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1994 | 936 | 0.020 |
Why?
|
| Hepatomegaly | 1 | 1992 | 22 | 0.020 |
Why?
|
| Thymidine | 1 | 1992 | 49 | 0.020 |
Why?
|
| Hemoglobin, Sickle | 1 | 1992 | 18 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 976 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 1993 | 170 | 0.020 |
Why?
|
| Splenomegaly | 1 | 1992 | 32 | 0.020 |
Why?
|
| Spleen | 1 | 1992 | 257 | 0.020 |
Why?
|
| Culture Media | 1 | 1991 | 169 | 0.020 |
Why?
|
| Leucine | 1 | 1992 | 258 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 1611 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1991 | 250 | 0.020 |
Why?
|
| Potassium | 1 | 1991 | 268 | 0.020 |
Why?
|
| Cell Division | 1 | 1991 | 718 | 0.020 |
Why?
|
| Granuloma, Foreign-Body | 1 | 1990 | 7 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 1994 | 1487 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1992 | 289 | 0.020 |
Why?
|
| Syndrome | 1 | 1992 | 1159 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 1456 | 0.020 |
Why?
|
| Necrosis | 1 | 1990 | 194 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1991 | 632 | 0.020 |
Why?
|
| Cell Cycle | 1 | 1992 | 597 | 0.020 |
Why?
|
| Psychometrics | 1 | 1993 | 674 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 2088 | 0.020 |
Why?
|
| Cell Line | 1 | 1993 | 2557 | 0.020 |
Why?
|
| Acute Disease | 1 | 1992 | 1145 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1993 | 1877 | 0.020 |
Why?
|
| Radiography | 1 | 1990 | 743 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1992 | 679 | 0.020 |
Why?
|
| Hemoglobin C Disease | 1 | 1987 | 2 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1987 | 54 | 0.020 |
Why?
|
| Prevalence | 1 | 1994 | 2687 | 0.020 |
Why?
|
| Calcium | 1 | 1991 | 1022 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 1995 | 1216 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 1217 | 0.020 |
Why?
|
| Cell Separation | 1 | 1987 | 220 | 0.020 |
Why?
|
| Proteins | 1 | 1991 | 1008 | 0.010 |
Why?
|
| Biopsy | 1 | 1990 | 1241 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1993 | 1921 | 0.010 |
Why?
|
| Azepines | 1 | 1986 | 62 | 0.010 |
Why?
|
| Hospitalization | 1 | 1995 | 1928 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1987 | 255 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1994 | 3031 | 0.010 |
Why?
|
| Glutathione Reductase | 1 | 1983 | 10 | 0.010 |
Why?
|
| Sickle Cell Trait | 1 | 1983 | 10 | 0.010 |
Why?
|
| Riboflavin Deficiency | 1 | 1983 | 8 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1992 | 3795 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2003 | 91 | 0.010 |
Why?
|
| Death, Sudden | 1 | 2003 | 45 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 318 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 422 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1990 | 1313 | 0.010 |
Why?
|
| Lung | 1 | 1990 | 1535 | 0.010 |
Why?
|
| Cause of Death | 1 | 2003 | 502 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1990 | 1540 | 0.010 |
Why?
|
| Risk Factors | 1 | 1994 | 10941 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1990 | 6438 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 308 | 0.010 |
Why?
|
| Urticaria | 1 | 1995 | 19 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1995 | 59 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1995 | 104 | 0.010 |
Why?
|
| Chest Pain | 1 | 1995 | 123 | 0.010 |
Why?
|
| Mice | 1 | 1992 | 18207 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1594 | 0.010 |
Why?
|
| Animals | 2 | 1992 | 33796 | 0.010 |
Why?
|
| Tissue Preservation | 1 | 1993 | 14 | 0.010 |
Why?
|
| Fever | 1 | 1995 | 309 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 227 | 0.010 |
Why?
|
| Erythrocyte Volume | 1 | 1991 | 3 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 254 | 0.010 |
Why?
|
| Biological Transport | 1 | 1991 | 329 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1991 | 396 | 0.010 |
Why?
|
| Potassium Channels | 1 | 1991 | 153 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 1084 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1991 | 1016 | 0.000 |
Why?
|
| United States | 1 | 2003 | 11859 | 0.000 |
Why?
|
| Middle Aged | 2 | 2003 | 28366 | 0.000 |
Why?
|
| Genotype | 1 | 1993 | 2590 | 0.000 |
Why?
|
| Rats | 1 | 1991 | 3368 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 414 | 0.000 |
Why?
|
| Aged | 1 | 2003 | 20859 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1986 | 1622 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1986 | 1122 | 0.000 |
Why?
|
| Diet | 1 | 1983 | 1100 | 0.000 |
Why?
|
| Time Factors | 1 | 1986 | 6197 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1993 | 17516 | 0.000 |
Why?
|